← Back to headlines
Lupin Signs Agreement with Tenpoint Therapeutics for YUVEZZI Commercialization
Lupin has entered into an exclusive agreement with Tenpoint Therapeutics to commercialize YUVEZZI in Europe and the UK, expanding its market reach.
20 Aug, 06:41 — 20 Aug, 06:41
Related Stories
Nvidia Nears $14 Billion Acquisition Deal for AI Startup Hugging Face
17m ago
US-Iran Strikes Trigger Oil Surge and Global Market Volatility
30m ago
Bessent Defends Economic Pressure Strategy Against Iran and Tariff Proposals
46m ago
Casablanca Airport Sets Daily Passenger Record Amid Summer Travel Surge
55m ago